How dysbiosis impairs GLP-1 signaling Gut dysbiosis, characterized by low bacterial diversity, overgrowth of inflammatory species, and reduced populations of beneficial bacteria, creates a cascade of metabolic problems
health systems to compare two groups: people with obesity and diabetes who took GLP-1 drugs and other people with the same conditions who took diabetes drugs like sitagliptin
Being more at risk might mean that they see greater benefits more quickly than people living with obesity but not prediabetes
It also helps to control the levels of hormones (estrogen and testosterone) and prostaglandins, which are broken down in the liver
Supplemental Table 2), indicating that the pattern of change in appetite before and after the drinking session differed between groups
If B12 is low and folate is normal, use D51.9